Summary. Cardiorespiratory reflexes were studied during slow breathing and a Valsalva maneuver in 232 Type 1 (insulin-dependent) diabetic subjects. At 1 to 7 years follow-up, death occurred in 23.4% of 175 patients with abnormal reflexes and in 3.5% of 57 patients with normal reflexes. The mortality rates of diabetic subjects with abnormal reflexes were 17% at 2.5 years, 33% at 5 years and 40% at 7 years, significantly higher than for patients with normal reflexes (4.6%, 4.6% and 13.8%). Among patients with abnormal reflexes, patients with a functioning pancreas transplantation had better survival rates than patients with a failed transplantation, and in long-term follow-up better than patients without transplantation. A functioning transplantation prevented the progressive decline of cardiorespiratory reflex function that occurred over time in control patients.
Introduction
Cardiorespiratory reflex (CRR) tests can detect abnormal cardiovascular function in as many as 75% of diabetic subjects (Hilsted and Jensen 1979; Dyberg et al. 1981; Ewing et al. 1985; Low et al. 1986; Zola et al. 1986; Kennedy et al. 1989 ), often at the time diabetes is first diagnosed (Canal et al. 1978; Pfeifer et al. 1984) , even though 27% or fewer have symptoms of autonomic dysfunction Canal et al. 1978; Young et al. 1983) . Moreover, abnormalities on CRR testing are generally considered to be associated with an increased frequency of sudden death (Page and Watkins 1978) and an increased mortality rate (Ewing et al. 1976; . Pancreas transplantation reinstitutes a normoglycaemic state in diabetic patients. This suggests that it may have the potential to halt or reverse the effects of diabetes on the nervous system. We therefore investigated the effect of a functioning pancreas transplantation on the CRRs.
We also studied the usefulness of CRR tests as predictors of prognosis and survival in 3 groups of Type l(insulindependen~ldiabetic patients. One group had a functioning pancreas transplantation, a second group had a pancreas transplantation that failed within 3 months and a third group had not received a pancreas transplantation.
Subjects and methods
We studied all patients with insulin dependent (Type 1) diabetes mellitus whose first CRR test was performed prior to December 31,1986. There were 232 patients, 94 men and 138 women, aged 33.2 + 9.2 years, with a duration of diabetes 20.2 + 9.1 years at entry into the cohort. Pancreas transplantation was performed on 137 patients; all were non-uraemic, either with their native kidneys or having received a kidney transplantation prior to or simultaneous with the pancreas transplantation. CRR tests were performed at the initial visit and at follow-up as described previously ). The averaged difference between the highest heart rate (HR) during inhalation and the lowest HR with exhalation during slow breathing at 6 per minute was called the AR6. The highest HR during a Valsalva manoever divided by the lowest rate within 30 s after the manoever was called the Valsalva ratio (VR). Normal limits were established for each age decade . We also recorded the number of patients who died before December 31, 1987 and the cause of death. Follow-up varied from 12 to 88 months, with 12 patients followed-up longer than 7 years. A pancreas graft was functioning in 53 cases on December 3 I, 1987 or at the time of death. The transplant had failed within less than 3 months in 65 patients and at intermediate times in the remaining 19 patients. Ninety-five patients had not received a pancreas transplantation. Survival estimates were calculated using life-table methods and analyzed statistically by the log-rank test. The effects of several variables on survival were analyzed using Cox proportional hazards regression test. Comparisons between groups were made using t-tests and Chi-square tests. Comparisons at several intervals during follow-up were made with the Wilcoxon signed rank test.
Resul~

Cardiorespiratory reflexes and mortality
Both CRR tests were abnormal in 152 patients, one test only was abnormal in 23 and both were normal in 57. There were statistically significant differences in age (P < 0.001), duration of diabetes (P < 0.001), results of CRR tests (P < 0.001), and degree of sensorimotor neuropathy (P < 0.05) between patients with normal and patients with abnormal results. The duration of follow-up was similar in the two groups.
Of the 232 patients, 43 died (18.5%) during the period of observation. The cause of death was myocardial infarction for 6, heart arrest for 4, heart failure for 2, pulmonary failure or distress for 4, liver failure for 4, kidney failure for 4, sudden death of unknown origin for 2, and individual cases with hyperglycaemia, hypoglycaemic coma, pulmonary embolism, lymphoma, anaphylactic shock, viral infection and drug overdose. There was no reliable information on the cause of death for 10 patients.
There were no differences between the deceased and survivors in age or duration of diabetes at entry into the study, but CRR test values were significantly lower for the deceased. In 40 of the deceased both test values were abnormal, one had 1 abnormal value and only 2 had normal CRR values. Mortality rates were 17% at 2.5 years, 33% at 5 years and 40% at 7 years for patients with abnormal CRR tests, and 4.6%, 4.6% and 13.8% at the same intervals for patients with normal test results. Figurel shows the survival curves for patients with normal and with abnormal CRR test results. Survival was significantly lower (p<0.002) for patients with abnormal results. Survival was not associated with sex, age, or duration of diabetes at entry into the study. (Reprinted with permission, Kennedy et al. 1989.) S 109 transplantation and 55 with a failed pancreas transplantation, clearly favoured the group with a functioning pancreas transplantation (p<0.005), whether considering all deceased patients (Fig. 2) or excluding those whose death was related to pancreas transplantation (40% in each group). Of the 95 patients without a pancreas transplantation, 62 had abnormal CRR test results. The survival curve of patients with abnormal CRR and a functioning pancreas transplantation was better on long-term follow-up than the curve of these 62 without a pancreas transplantation (Fig.2) , despite the risks intrinsic to surgery and immunosuppression and the higher proportion with abnormal CRR results. 
Influence of pancreas transplantation on cardiorespiratory reflexes over time
Serially repeated testing during the follow-up time was obtained in 47 patients with a functioning pancreas transplantation and in 36 with either a failed pancreas transplantation or without a pancreas transplantation. The data in Table 2 indicate that autonomic dysfunction worsens significantly with time in the latter group (NoPTx); in contrast, CRR test values remained the same or slightly improved for patients with a functioning pancreas transplantation.
Influence of pancreas transplantation on survival Discussion
Comparison of patients with a functioning pancreas graft with those whose grafts had failed within 3 months did not show statistically significant differences with respect to age, duration of diabetes or degree of neuropathy (Table  1) . Five of 53 patients with a functioning pancreas transplantation had died; the death of 2 was attributed to complications of the surgical procedure or the immunosuppressive treatment. All 5 had abnormal CRR function. Of 65 patients with a failed pancreas transplantation, 22 had died, 9 from causes related to pancreas transplantation. Only one had normal CRR test results. The survival curves of patients with abnormal CRR results, 43 with a functioning pancreas
The prevalence of autonomic dysfunction in diabetic patients, judged by abnormalities of cardiovascular reflex responses, is reported from 20 to 75% (Hilsted and Jensen 1979; Dyberg et al. 1981; Ewing et al. 1985; Low et al. 1986; Zola et al. 1986; Kennedy et al. 1989 ). The 75% of our patients with abnormal CRR results is similar to the proportion found in a larger series of 417 patients ). This high rate is probably influenced by the characteristics of the population studied. Most of the patients were referred for various therapeutic trials including pancreas transplantation. In the latter, diabetes was usually of long duration and associated with overt secondary complications. The natural history of diabetic autonomic neuropathy is of slow progression. CRR test results are abnormal in a high percentage of patients with symptoms of autonomic dysfunction but also in those who deny symptoms Canal et al. 1978; Pfeifer et al. 1984; Watkins and Mackay 1980) . Once abnormal, CRR function remains so, often deteriorating with time (Ewing et al. 1985; Watkins and Mackay 1980) , as also shown in this study. Ewing et ai. (Ewing et al. 1976; followed patients with symptoms of autonomic neuropathy and with abnormal cardiovascular tests. They found a mortality rate of 44% at 2.5 years and 56% at 5 years, much higher than the 6% and 11% rates at the same time points in a general diabetic population. Watkins and Mackay (Watldns and Mackay 1980) found that 27% of 64 diabetic patients with abnormal heart rate variation during slow breathing died during a 5 year follow-up, 4 of sudden death. These results are in general agreement with our findings of mortality rates of 17% at 2.5 years and 33% at 5 years. Of our 175 patients with abnormal CRR test results, 41 died during follow-up, whereas only 2 of 57 patients with normal results died. These observations conf'mn the view that diabetic patients with evidence of autonomic dysfunction have a higher mortality risk than patients with normal test results. A high mortality risk is also reported to be associated with other abnormalities of nerves; such as gastroparesis (Zitomer et al. 1968 ) and somatic polyneuropathy , as well as with other secondary complications of diabetes mellitus, such as vascular disease, nephropathy (Grenfell and Watkins 1986 ) and retinopathy (Klein et al. 1989) .
The relationship between excessive mortality and an abnormal CRR in diabetic patients is not completely understood. An abnormal CRR is often associated with an abnormal blood pressure response to respiratory manoevers and to changes in posture (Ferrer et al. 1990; Kennedy et al. 1991) . The frequency of myocardial infarction and the mortality rate (Niakan et al. 1986; Abbot et al. 1988 ) are known to be high among diabetic patients. Heart disease was the most frequent cause of death (28%) in our patients. In addition, approximately one third of diabetic patients show evidence of depressed ventricular function in the absence of ischaemia (Zola et al. 1986 ). Other abnormalities, found with high prevalence among diabetics with autonomic neuropathy, that should also be considered as possible causes of death are disorders in the reflex control of ventilation (Williams et al. 1984; Sobotka et al. 1986 ) resulting in sudden death (Page and Watkins 1978) , and marked postural hypotension that results in diminished cerebral blood flow in certain circumstances. In our patients renal disease was found to be the cause of death less frequently than in other studies (Ewing et al. 1976; . This was probably due to the high success rate of kidney transplantation in diabetic patients at our institution for over two decades (Najarian et al. 1989) .
Improved glycaemic control by exogenous insulin has not been shown to reverse established symptoms or signs of autonomic neuropathy (Ewing and Clarke 1986; The St. Thomas Diabetic Study Group 1986) . No improvement of cardiovascular function tests was found during insulin infusion therapies (Bertelsmann et al. 1987 ). Treatment Slll with aldose reductase inhibitors was initially thought to improve certain features of autonomic nerve function (Jaspan et al. 1983 ), but it has not produced significant changes in other studies (Martyn et al. 1987) . Although a functioning pancreas graft has not resulted in clear improvement of CRR test results, there are indications that it may slow or halt the progress of the autonomic neuropathy (Solders et al. 1987; Kennedy et al. 1990 ). In one institution the presence of autonomic neuropathy has been proposed as one inclusion criteria for pancreas transplantation in diabetic patients without end-stage neuropathy (The University of Michigan Pancreas Transplant Evaluation Committee 1988). Our patients with abnormal CRR test results had a better survival rate, if they maintained a functioning pancreas transplantation, than patients who underwent the same surgical procedure unsuccessfully and possibly better than patients without transplantation. At this time therefore, a functioning pancreas graft appears to offer diabetic patients the best chance of arresting the autonomic neuropathy and of prolonging survival.
